Instructions for Use 

OSTENIL® TENDON

Sodium hyaluronate from fermentation 2.0%. Viscoelastic solution for peritendinous or intrasheath injection. Sterile by moist heat.

COMPOSITION:

1ml isotonic solution contains 20.0mg sodium hyaluronate and sodium chloride, disodium phosphate, sodium dihydrogen phosphate, mannitol and water for injections.

INDICATIONS:

For the treatment of pain and reduced mobility in tendon disorders.

CONTRA-INDICATIONS:

OSTENIL® TENDON should not be used in patients with ascertained hypersensitivity to any of the constituents.

INTERACTIONS:

No information on the incompatibility of OSTENIL® TENDON with other medications administered to tendons is available to date.

Undesirable EFFECTS:

Local secondary phenomena such as pain, feeling of heat, bruising, redness or swelling may occur following treatment with OSTENIL® TENDON.

DOSAGE AND ADMINISTRATION:

Inject OSTENIL® TENDON around the affected tendon or into the affected tendon sheath. Several tendons may be treated at the same time. Repeat treatments may be administered as required. 

The content and outer surface of the OSTENIL® TENDON pre-filled syringe are sterile as long as the sterile pack remains unbroken. Take the pre-filled syringe out of the sterile pack, unscrew the Luer-Lock cap, attach a suitable needle (e.g. 25 to 27 G) and secure it by turning slightly. Remove any air bubble, if present, before injection.

PRECAUTIONS:

Caution should be exercised in patients with known hypersensitivity to medicinal products. As with all invasive treatments in very rare cases an infection may occur. Hence, the general precautions for peritendinous and intrasheath injections should be observed. OSTENIL® TENDON should be instilled accurately into the tendon sheath or around the affected tendon, if necessary under imaging control. Avoid nerve lesions and injections into blood vessels! As no clinical evidence is available on the use of OSTENIL® TENDON in children, pregnant and lactating women as well as in acute traumas, the treatment with OSTENIL® TENDON is not recommended in these cases. Do not use if the pre-filled syringe or the sterile blister are damaged. Any solution not used immediately after opening must be discarded. Otherwise the sterility is no longer guaranteed and this may be associated with a risk of infection. Store between 2 °C and 25 °C! Do not use after the expiry date indicated on the box! Keep out of the reach of children!

CHARACTERISTICS AND MODE OF ACTION:

A tendon is a strong structure of fibrous connective tissue designed to transmit forces from muscle to bone and resist load during muscle contraction. Tendons may be surrounded by different structures: fibrous bands, synovial sheaths, peritendon sheaths, tendon bursae. Overuse or inappropriate biomechanical stress may cause inflammation and/or degenerative changes of the tendon, leading to pain and loss of function. Lubricating the tendon could reduce pain, improve tendon function and reduce the potential for adhesions.

Because of its lubricating and viscoelastic properties OSTENIL® TENDON promotes tendon gliding and the physiological repair process. In addition, due to its macromolecular meshwork OSTENIL® TENDON reduces the free passage of inflammatory cells and molecules.

OSTENIL® TENDON is a transparent solution of natural and highly purified sodium hyaluronate obtained by fermentation and is devoid of animal protein. OSTENIL® TENDON also contains mannitol, a free radical scavenger, which helps to stabilise the chains of sodium hyaluronate. In biocompatibility studies OSTENIL® TENDON was found to be particularly safe.

PRESENTATION:

One pre-filled syringe of 40mg/2.0ml OSTENIL® TENDON in a sterile pack. 

OSTENIL® TENDON is a medical device. To be used by a clinician only. 

Last revision date: 2017-03

Manufactured by:
TRB CHEMEDICA AG
Otto-Lilienthal-Ring 26
85622 Feldkirchen/Munich, Germany

Downloads

Ostenil Range Brochure
Ostenil Range Brochure 2014 version
pdf document 1.19 MB
Ostenil Tendon Brochure
Ostenil® Tendon product information brochure
pdf document 3.34 MB
Ostenil Tendon Patient Information
Ostenil® Tendon patient information leaflet 2012 revision
pdf document 1.8 MB
Ostenil Tendon SmPC
Ostenil® Tendon summary of product characteristics data sheet
pdf document 244 KB
Patient Injection Diary
Patient injection and pain recording diary
pdf document 45.8 KB